Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Bronstein Ben Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2023 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 21,222 options to buy @ $8.39, valued at $178.1k
Granted 1,372 options to buy @ $8.39, valued at $11.5k
Granted 1,464 options to buy @ $8.39, valued at $12.3k
06/29/2023 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Exercised 9,604 options to buy @ $0.552, valued at $5.3k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2020 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 26,503 options to buy @ $5.02, valued at $133k
Granted 2,311 options to buy @ $5.02, valued at $11.6k
Granted 1,541 options to buy @ $5.02, valued at $7.7k
09/19/2019 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Bought 1,700 shares @ $5.85, valued at $9.9k
06/06/2019 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 18,951 options to buy @ $7.06, valued at $133.8k
Granted 1,653 options to buy @ $7.06, valued at $11.7k
Granted 1,102 options to buy @ $7.06, valued at $7.8k
06/08/2018 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 15,526 options to buy @ $8.35, valued at $129.6k
Granted 1,354 options to buy @ $8.35, valued at $11.3k
Granted 903 options to buy @ $8.35, valued at $7.5k
06/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/10/2016 4 Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 6,083 options to buy @ $5.97, valued at $36.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy